In mammals, four different genes encode four PMCA (plasma-membrane Ca 2+ -ATPase) isoforms. PMCA1 and 4 are expressed ubiquitously, and PMCA2 and 3 are expressed predominantly in the central nervous system. More than 30 variants are generated by mechanisms of alternative splicing. The physiological meaning of the existence of so many isoforms is not clear, but evidently it must be related to the cell-specific demands of Ca 2+ homoeostasis. Recent studies suggest that the alternatively spliced regions in PMCA are responsible for specific targeting to plasma membrane domains, and proteins that bind specifically to the pumps could contribute to further regulation of Ca 2+ control. In addition, the combination of proteins obtained by alternative splicing occurring at two different sites could be responsible for different functional characteristics of the pumps.
Introduction

Ca
2+ signalling modulates some of the most important processes, including cell origin at fertilization, stimulus-contraction and stimulus-secretion coupling, intracellular communication, gene transcription, cell growth and apoptotic cell death. The correct functioning of these processes demands that the concentration of Ca 2+ in the cytoplasm and in the different intracellular compartments must be tightly controlled. Alterations in this control may lead to various cell dysfunctions and diseases, and may even culminate in cell death.
The PMCA (plasma-membrane Ca 2+ -ATPase) and the plasma membrane NCX (Na + /Ca 2+ exchanger) are the two main mechanisms responsible for Ca 2+ removal from cells and are thus essential for the control of Ca 2+ homoeostasis. PMCAs have high Ca 2+ affinity but low capacity for Ca 2+ transport, whereas NCXs have low affinity but high transport capacity. Hence, PMCA is traditionally considered important as a regulator of the cytosolic free Ca 2+ concen- tration at basal levels (approx. 100 nM), whereas the NCX is thought to be responsible for the control of the large Ca 2+ fluctuations occurring in excitable cells such as neurons or myocytes. The possibility that the numerous PMCA isoforms and alternative splice variants could have specific roles in Ca 2+ handling and may be designed to respond to tissue-and cell-specific demands has attracted considerable attention. Furthermore, it has also become evident that differences in regulation of Ca 2+ removal could occur in polarized cells following the targeting of different PMCA isoforms to specific plasma membrane domains, such as the apical membrane of cochlear cells or parotid acinar cells and the basolateral membrane of kidney epithelial cells. Recent studies suggest that alternatively spliced regions in the PMCA are responsible for the specific targeting to plasma membrane domains and that specific proteins could bind to the pumps to contribute to the specialization of their function in controlling the Ca 2+ signal [1] . If seen from this perspective, the PMCA pumps appear as a dynamic system enabling cells to respond to the changing needs of Ca 2+ regulation.
PMCA structure, mechanism and regulation
The primary structure of the pump was deduced independently by Shull and Greeb [2] and Verma et al. [3] in 1988, using rat brain and human teratoma cDNA libraries respectively. Soon after the appearance of the first cloning, it became clear that the pump was the product of a multigene family with four distinct members recognized in animals. Two of the four gene products (PMCA1 and 4) were detected in all tissues and are thus now considered as housekeeping pumps (however, PMCA4 appears to be absent from rat liver [4] ). In contrast PMCA2 was found primarily in brain and heart, and PMCA3 in brain and skeletal muscle. Significant sequence differences (70-80% identity) were detected among the products of the four genes, additional isoform variability being produced by alternative mRNA splicing at two locations, termed splice sites A and C. An additional alternative splicing site has been proposed (site B) in the C-terminal portion of the pump, leading to the exclusion of a 108 bp exon, which would cause the loss of the tenth transmembrane domain of the protein. This probably represents an aberrant splicing site; even if mRNAs lacking the 108 bp exon have been detected in intestine and liver, no protein lacking the tenth transmembrane domain has so far been identified [5, 6] . PMCA pumps were predicted to be organized with ten transmembrane domains with approx. 80% of the pump mass protruding into the cytosol with an N-terminal sequence of approx. 90 residues, two main central domains and a long C-terminal tail downstream of the tenth transmembrane domain. The first central domain protrudes between transmembrane domains 2 and 3; it contains a basic stretch of amino acids which is the main site of interaction with activatory acidic phospholipids [7] . It also contains one of two binding sites for the autoinhibitory C-terminal calmodulin-binding domain. The second (and largest) cytosolic unit connects transmembrane domains 4 and 5, and contains the active site of the pump and the other binding site for the C-terminal calmodulin-binding domain. The cytosolic C-terminal tail contains the most important regulatory sites of the pump, including the calmodulin-binding domain and consensus sites for protein kinases A and C. The calmodulin-binding domain, owing to its basic character, also binds acidic phospholipids [8] and thus could also mediate the response of the pump to them. It also contains Ca 2+ -binding sites, separate from the catalytic sites, which are proposed to have an allosteric role [9] .
The pump isoforms generated by alternative splicing in the C-terminal region (site C) are of particular interest, since the C-terminal tail contains the calmodulin-binding site. This domain, in the absence of calmodulin, interacts with the main body of the pump, and keeps it inactive. Calmodulin displaces the domain from the intramolecular receptors, removing the inhibition. C-site splicing occurs in all pump isoforms and causes the inclusion of one (or two) additional exons, or portion of exons, leading to truncated pumps which display a shorter regulatory domain as compared with the full-length isoform. The truncated version of the pump is named CII or a, the full-length isoform is named CI or b. The second site of alternative splicing is located closer to the 5 end of the gene (site A) in the cytosolic portion that connects the second to the third transmembrane domain of the pump. This portion is considered to be the 'transducer domain' of the pump, since it seems to be involved in the conformational changes occurring during the transport cycle. Depending on the isoform, splicing at site A introduces one or more exons in the pump structures.
One plausible way to rationalize the existence of so many PMCA isoforms would be by suggesting that they play differential roles in the control of Ca 2+ signalling in selected cell microdomains. For example, different PMCA isoforms could be recruited to specific regions of the plasma membrane by binding to particular proteins (Figure 1) , and recent evidence indicates that this may indeed occur (see below). PMCA isoforms 2CI (2b) and 4CI (4b) interact promiscuously and selectively with members of the MAGUK (membraneassociated guanylate kinase) family of PDZ domaincontaining proteins which are known to cluster ion channels with other signalling proteins [10, 11] . The interaction has been demonstrated by yeast two-hybrid screening using the C-terminal tail of PMCA 2CI (2b) and 4CI (4b), and in coimmunoprecipitation experiments. The work has suggested that PMCA-MAGUK interactions mediate the recruitment and maintenance of PMCA at specific membrane domains involved in local Ca 2+ regulation. It was also reported that PMCA 2CI (2b) interacts preferentially with NHERF2 (Na + /H + exchanger regulatory factor 2), which is another PDZ domain-containing protein, involved in the targeting, retention and regulation of membrane proteins such as the β 2 -adrenergic receptor, the cystic fibrosis transmembrane conductance regulator and TRP4 (transient receptor potential 4) Ca 2+ channels [12] . Interestingly, overexpressed GFP (green fluorescent protein)-tagged PMCA 2CI (2b) in MDCK (Madin-Darby canine kidney) (epithelial) cells is sorted to the apical membrane, where it co-localizes with transfected NHERF2. Again, this suggests a possible mechanism for the apical sorting of PMCAs in epithelial cells. These initial results are interesting, but should still be treated with caution, since apical targeting of the pump also occurred in the absence of exogenously expressed NHERF2. Interaction between the PMCA pump and the inducible NOS-I (nitric oxide synthase I) has also been described [13] . PMCA isoform 4CI (4b) is claimed to be concentrated in the caveolae [14, 15] , which contain a number of effectors of cellular signal transduction. It interacts through its C-terminal region with the PDZ domain of NOS-I. The interaction appears to be specific for NOS-I, as it failed to occur with endothelial NOS [13] . The authors of the study have proposed a model in which a PMCA molecule interacting with NOS-I might reduce the local (caveolar) Ca 2+ concentration, leading to reduced NOS-I activity [13] . The proposal was supported by experiments in which increasing PMCA 4CI (4b) expression reduced the NOS-I-dependent cGMP-cyclase activity, supporting the proposal that PMCA 4CI (4b), by virtue of its interaction with NOS-I, decreased the concentration of Ca 2+ in its immediate vicinity, thus down-regulating its activity [13] . Another member of the MAGUK family, CASK (calcium/calmodulin-dependent serine protein kinase) was recently found to interact with PMCA 4CI (4b) [16] . CASK is of particular interest since in adult brain it is located at neuronal synapses, where the presence of a Ca 2+ removal system in its immediate proximity could contribute to the regulation of synaptic activity [16] . PMCA interactions with PISP (PMCA-interacting single-PDZ protein) [17] and with the Ania-3/Homer protein [18] , have also been described. Pull-down experiments have shown that PISP interacts with all PMCA CI (b) isoforms. PISP was found to be ubiquitously expressed and, in MDCK cells, was present in a punctate pattern throughout the cytosol and at the basolateral membrane. When added to microsomal signalling, and hence synaptic function, can be modulated in neurons. Other studies searching for PMCA-binding proteins have focused on the main intracellular loop of the pump, identifying calcineurin [19] and the tumour suppressor RASSF1 (Ras-associated factor 1) as binding partners [20] . A recent study from our group used the N-terminal region of the PMCA pumps as a possible binding site for protein partners as it has very low sequence homology in the isoforms. The study has identified isoform ε of the 14-3-3 protein as a specific interactor for PMCA4, but not for PMCA2 [21] , and discovered that the interaction is inhibitory.
PMCA2 alternative splicing mechanisms and mutations associated with hereditary hearing loss
Alterations in the pumping function of the PMCA pumps have been described in a number of conditions, but the only genetic defect so far described is that of PMCA2, where mutations produce hereditary hearing loss (Figure 2) . The defect was originally described in mice, the best characterized being the deafwaddler mouse (dfw) in which a missense mutation (G283S) alters the pumping function of PMCA2 [22] . In another mouse model, the Wriggle Mouse Sagami (wri), a mutation occurs in transmembrane domain 4 (E412K) [23] . Homozygous wri mice suffer from a neurological disorder characterized by motor imbalance and progressive hearing loss. A third mutation has also been described where a 2 bp deletion causes loss of the reading frame that leads to a truncated pump (dfw 2j ) and to its disappearance from the stereocilia and the basolateral membrane of cochlear hair cells [22, 23] . The PMCA2 gene has been knocked out [24] , producing mice with equilibrium defects and deafness. Histology of these mice show an increased number of Purkinje neurons in the cerebellum and severe abnormalities in the vestibular system and in the organ of Corti.
Recently, genetic defects leading to hearing loss have also been described in humans [25, 26] ; however, the genetic defects of the pump alone did not produce the deafness phenotype in the cases so far described. One mutation (V586M) increases the severity of hearing loss in a family having a homozygous point mutation in cadherin 23 (CDH23). We Approximate locations of mutations are indicated. KO refers to a null mutant mouse generated by interrupting exon 19, which encodes transmembrane region 8 of the pump [24] .
have recently identified a novel PMCA2 mutation (G293S) that, in association with a new mutation in the CDH23 gene, produces hearing loss [26] through a mechanism of digenic inheritance.
In the function of the inner ear, Ca 2+ acts as a key modulator of MET (mechanoelectrical transduction) by hair cells, the sensory cells of the organ. The sensory organelle of the hair cell, the hair bundle, which is exposed to an extracellular fluid that is high in K + and low in Na + , relies on mobile Ca 2+ buffers and on the PMCA to regulate Ca 2+ levels in stereocilia. The ATPase exports Ca 2+ that enters through the MET channels [27, 28] and it has been discovered that hair cells contain a large amount of the PMCA pump, particularly in the hair bundle. Interestingly, PMCA 1CI (1b) is the major enzyme of hair cells and of the supporting cell basolateral membranes, whereas the C-terminally truncated PMCA 2CII (2a) variant is the only isoform present in the hair bundles. The situation of PMCA2 alternative splicing at site A is particularly complex: three exons, of 33, 60 and 42 bp respectively, can be alternatively introduced. To date, only four isoforms have been recognized: the AIII or w variant (all three exons included), the AI or z variant (all three exons excluded), the AII or x variant (where only the exon of 42 bp is included) and the AIV or y variant (in which the exons of 33 and 60 bp are included).
Recent work has shown that PMCA 2CII (2a) of the stereocilia is also spliced at site A, and is thus the AIII,CII (w/a) isoform [1] . It is plausible to assume that the choice of this unusual isoform of the PMCA [29] was dictated by the special Ca 2+ homoeostasis demands of the surroundings in which the pump must operate. Significantly, Ca 2+ concentration in the endolymph that bathes the stereocilia is in the low micromolar range, and is thus orders of magnitude lower than in all other extracellular fluids. To investigate and compare the activity of splice isoforms AI,CI (z/b), AI,CII (z/a), AIII,CI (w/b) and AIII,CII (w/a), we co-transfected their expression plasmids together with the vector for the expression of the recombinant Ca 2+ -sensitive photoprotein aequorin (cytAEQ) in CHO (Chinese hamster ovary) (epithelial) cells (Figure 3) . The overexpression of all four isoforms of the pump had clear effects on the amplitude of the transient cytosolic Ca 2+ generated following cell stimulation with the purinergic receptor agonist ATP and on the speed of the return of the Ca 2+ trace to baseline. The lowering of the Ca 2+ peak with respect to untransfected cells is likely to reflect the ability of pump isoforms to respond immediately with a burst of activation to counter the Ca 2+ pulse. The fast clearance of the cytosolic Ca 2+ signal is easily explained by the increased pump activity. Two of the splice variants [AI,CII (z/a) and AIII,CI (w/b)] behaved essentially as the full-length non-inserted AI,CI (z/b) pump, which is a very active PMCA isoform. In contrast, the doubly inserted variant AIII,CII (w/a) was less able to control the height of the Ca 2+ peak, i.e. it was less able to react rapidly to the arrival of a Ca 2+ pulse [30] . The effects of the dfw mice mutation of the pump on its Ca 2+ -exporting function were then studied. As mentioned above, in the mutant pump, a glycine residue, embedded in a sequence highly conserved among all PMCA isoforms in the The plasma-membrane Ca 2+ pump and the MET channel are indicated. G283S and G293S mutations reduce the ability of the PMCA to remove Ca 2+ , decreasing the endolymphatic Ca 2+ concentration, thus increasing the open probability of MET channels [26] .
first cytosolic loop between transmembrane domains 2 and 3 (Gly 283 ), is replaced by serine [22] . The G283S mutation had been found to reduce the Ca 2+ -transport activity of the pump to approx. 30% [31] . We have compared the activity of the dfw (G283S) mutated pump with that of the human G293S mutant in CHO cells. We found that the compromised function was not in fact the ability of the pump to respond to a sudden demand for hyperactivity, which was about the same as in the wild-type AIII,CII (w/a) isoform, but was the special ability to operate efficiently at the non-activated level (Figure 3) . The mutations impaired the long-term export of Ca 2+ [26] , a defect that could influence the fraction of MET channels open at rest in hair cells. By increasing Ca 2+ near the stereocilia tips, the pump would augment the probability of a MET channel block and increase the rate of adaptation. Conversely, lowering the Ca 2+ concentration would reduce the rate of adaptation and increase the open probability and channel unitary conductance [32] . 
